Please use this identifier to cite or link to this item:
http://repository.tma.uz/xmlui/handle/1/5135
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Зокирхўжаев Шерзод Яхъяевич, Паттахова Малика Хусановна | - |
dc.date.accessioned | 2022-12-14T04:46:43Z | - |
dc.date.available | 2022-12-14T04:46:43Z | - |
dc.date.issued | 2022 | - |
dc.identifier.uri | http://repository.tma.uz/xmlui/handle/1/5135 | - |
dc.description.abstract | In scientific studies on the study of COVID-19, the researchers have reported that 14-53% of the cases showed signs of mild to moderate liver damage: increased levels of aminotransferases, hypoproteinemia, and an increase in prothrombin time. The severe course of the disease was associated with signs of liver damage. Exacerbation of pre-existing chronic liver disease leads to a more severe course of COVID-19 infection. The direct action of the SARS-CoV-2 virus can directly affect liver cells, as evidenced by the detection of increased expression of ACE-2 receptors in cholangiocytes [1,2]. Patients with advanced stages of chronic diffuse liver disease have a higher risk of infection due to immune disorders associated with the presence of cirrhosis [3]. The aim of the study was to study the clinical, functional and metabolic characteristics of patients with chronic hepatitis who had Covid-19. | en_US |
dc.language.iso | en_US | en_US |
dc.publisher | Америка | en_US |
dc.subject | Chronic hepatitis, Covid-19, Inflammation, Damage | en_US |
dc.title | Clinical Features and Lab Values of Patients with Chronic Hepatitis after Covid-19 | en_US |
dc.type | Article | en_US |
Appears in Collections: | Thesis, Articles |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Зокирхужаев, Паттахова.pdf | Clinical Features and Lab Values of Patients with Chronic Hepatitis after Covid-19 | 154.58 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.